| Viable pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy M Burotto, JG Gormaz, S Samtani, N Valls, R Silva, C Rojas, S Portiño, ... Seminars in oncology 45 (3), 164-169, 2018 | 71 | 2018 |
| STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ... Lung Cancer 170, 114-121, 2022 | 22 | 2022 |
| Is cytoreductive nephrectomy still a standard of care in metastatic renal cell carcinoma? A Renner, S Samtani, A Marín, M Burotto Journal of Kidney Cancer and VHL 6 (1), 1, 2019 | 21 | 2019 |
| Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: The THOCOoP cooperative group O Arrieta, AF Cardona, L Lara-Mejia, D Heredia, F Barron, ... Critical Reviews in Oncology/Hematology 153, 103033, 2020 | 20 | 2020 |
| MET signaling pathways, resistance mechanisms, and opportunities for target therapies S Rivas, A Marín, S Samtani, E González-Feliú, R Armisén International Journal of Molecular Sciences 23 (22), 13898, 2022 | 19 | 2022 |
| Primary adrenal insufficiency during immune checkpoint inhibitor treatment: case reports and review of the literature C Salinas, A Renner, C Rojas, S Samtani, M Burotto Case Reports in Oncology 13 (2), 621-626, 2020 | 16 | 2020 |
| p. G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics A Ruiz-Patino, J Rodríguez, AF Cardona, J Ávila, P Archila, H Carranza, ... Translational oncology 15 (1), 101276, 2022 | 14 | 2022 |
| The role of a cachexia grading system in patients with non-small cell lung cancer treated with immunotherapy: implications for survival JG Turcott, JE Martinez-Samano, AF Cardona, SS Bassarmal, ... Nutrition and Cancer 73 (5), 794-801, 2021 | 12 | 2021 |
| Outcomes of sepsis and septic shock in cancer patients: focus on lactate R López, R Pérez-Araos, F Baus, C Moscoso, Á Salazar, J Graf, ... Frontiers in medicine 8, 603275, 2021 | 10 | 2021 |
| Association of lung adenocarcinoma subtypes according to the IASLC/ATS/ERS classification and programmed cell death ligand 1 (PD-L1) expression in tumor cells G Cruz-Rico, A Avilés-Salas, X Popa-Navarro, L Lara-Mejía, R Catalán, ... Pathology and Oncology Research 27, 597499, 2021 | 10 | 2021 |
| Association of carcinoembryonic antigen reduction with progression-free and overall survival improvement in advanced non-small-cell lung cancer O Arrieta, E Varela-Santoyo, AF Cardona, R Sánchez-Reyes, ... Clinical Lung Cancer 22 (6), 510-522, 2021 | 8 | 2021 |
| Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an … DF Chamorro, AF Cardona, J Rodríguez, A Ruiz-Patiño, O Arrieta, ... Targeted Oncology 18 (3), 425-440, 2023 | 7 | 2023 |
| Status of breast cancer in Latin American: results of the breast cancer revealed initiative N Ayala, S Barchuk, G Inurrigarro, C Celano, JL Soriano-García, ... Critical Reviews in Oncology/Hematology 181, 103890, 2023 | 7 | 2023 |
| Mechanisms of resistance to first-line osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (FRESTON-CLICaP) AF Cardona, A Ruiz-Patiño, G Recondo, C Martín, L Raez, S Samtani, ... Clinical Lung Cancer 23 (6), 522-531, 2022 | 7 | 2022 |
| Durvalumab after chemoradiation for unresectable stage III non-small cell lung cancer: inferior outcomes and lack of health equity in hispanic patients treated with PACIFIC … LE Raez, O Arrieta, DF Chamorro, PD Soberanis-Piña, L Corrales, ... Frontiers in oncology 12, 904800, 2022 | 7 | 2022 |
| Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC L Lara-Mejía, AF Cardona, L Mas, C Martin, S Samtani, L Corrales, ... Journal of Thoracic Oncology 19 (1), 119-129, 2024 | 6 | 2024 |
| RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin W Muñoz-Montaño, S Muñiz-Hernández, A Avilés-Salas, R Catalán, ... BMC cancer 21, 1-11, 2021 | 6 | 2021 |
| Lung cancer in Chile M Burotto, O Aren, A Renner, S Samtani, JJ de la Jara Journal of Thoracic Oncology 14 (9), 1504-1509, 2019 | 6 | 2019 |
| Survival of critically ill oncologic patients requiring invasive ventilatory support: a prospective comparative cohort study with nononcologic patients R López, SR Samtani, JM Montes, R Perez, MJ Martin, A Salazar, J Graf Journal of Global Oncology 5, 1-8, 2019 | 6 | 2019 |
| Cómo enfrenta el hinduismo un dilema ético-clínico S Samtani, M Jadue, JP Beca Revista médica de Chile 137 (11), 1511-1515, 2009 | 5 | 2009 |
